BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30905434)

  • 21. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
    Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
    Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
    Chang AJ; Richardson S; Grigsby PW; Schwarz JK
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):263-9. PubMed ID: 21167656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Guler OC; Reyhan M; Yapar AF
    Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes.
    Grigsby PW; Perez CA; Chao KS; Herzog T; Mutch DG; Rader J
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):733-8. PubMed ID: 11172956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
    Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
    Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
    Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
    Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of distant metastatic disease by positron emission tomography with
    Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
    Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
    Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
    Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
    Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
    Lin AJ; Dehdashti F; Massad LS; Thaker PH; Powell MA; Mutch DG; Schwarz JK; Markovina S; Siegel BA; Grigsby PW
    Clin Oncol (R Coll Radiol); 2021 May; 33(5):300-306. PubMed ID: 33581976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
    Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Kim TH; Kim MH; Kim BJ; Park SI; Ryu SY; Cho CK
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1124-1131. PubMed ID: 28721896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.